Literature DB >> 29258343

Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery.

Jia-Lin Huang1,2, Hong-Zhuan Chen1, Xiao-Ling Gao1.   

Abstract

In recent years, lipid-coated calcium-phosphate (LCP) nanoparticle has been developed as a versatile platform for delivery of various therapeutics including gene, protein/peptide, chemotherapeutics and theranostic agents. The high endosomal escape, coupled with the ability to efficiently encapsulate phosphorylated drugs or prodrugs, make LCP become attractive vehicle for drug delivery. Additionally, the principle behind LCP formulation has also allowed rational design of LCP-derived nanoparticles (NPs) with other solid core or lipid membrane to overcome the various drug delivery barriers. Here, we briefly review the history of the development of LCP NPs, highlight the optimisations and modulations in the development process, and summarise the major applications of LCP NPs and LCP-derived NPs in drug delivery.

Entities:  

Keywords:  Liposome; calcium phosphate; drug delivery; endosomal escape; lipid-coated calcium-phosphate nanoparticles; reconstituted high-density lipoprotein

Mesh：

Substances：

Year:  2017        PMID： 29258343     DOI： 10.1080/1061186X.2017.1419360

Source DB:  PubMed          Journal:  J Drug Target        ISSN： 1026-7158            Impact factor:   5.121


  9 in total

Review 1.  Liposomal delivery of CRISPR/Cas9.

Authors:  Shuai Zhen; Xu Li
Journal:  Cancer Gene Ther       Date:  2019-11-02       Impact factor: 5.987

Review 2.  Lipid-Based Nano-Sized Cargos as a Promising Strategy in Bone Complications: A Review.

Authors:  Supandeep Singh Hallan; Jhaleh Amirian; Agnese Brangule; Dace Bandere
Journal:  Nanomaterials (Basel)       Date:  2022-03-30       Impact factor: 5.076

3.  Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment.

Authors:  Jing Zhang; Peng Zhang; Qian Zou; Xiang Li; Jianjiang Fu; Ying Luo; Xinli Liang; Yi Jin
Journal:  Molecules       Date:  2018-11-07       Impact factor: 4.411

4.  Enhancing PD-1 Gene Silence in T Lymphocytes by Comparing the Delivery Performance of Two Inorganic Nanoparticle Platforms.

Authors:  Yanheng Wu; Wenyi Gu; Li Li; Chen Chen; Zhi Ping Xu
Journal:  Nanomaterials (Basel)       Date:  2019-01-28       Impact factor: 5.076

Review 5.  Noncoding RNAs in cancer therapy resistance and targeted drug development.

Authors:  Wen-Tao Wang; Cai Han; Yu-Meng Sun; Tian-Qi Chen; Yue-Qin Chen
Journal:  J Hematol Oncol       Date:  2019-06-07       Impact factor: 17.388

Review 6.  Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope.

Authors:  Lucia Salvioni; Maria Antonietta Rizzuto; Jessica Armida Bertolini; Laura Pandolfi; Miriam Colombo; Davide Prosperi
Journal:  Cancers (Basel)       Date:  2019-11-25       Impact factor: 6.639

Review 7.  Targeted Delivery Methods for Anticancer Drugs.

Authors:  Valery V Veselov; Alexander E Nosyrev; László Jicsinszky; Renad N Alyautdin; Giancarlo Cravotto
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

8.  Boosting nutrient starvation-dominated cancer therapy through curcumin-augmented mitochondrial Ca2+ overload and obatoclax-mediated autophagy inhibition as supported by a novel nano-modulator GO-Alg@CaP/CO.

Authors:  Xuan Wang; Yunhao Li; Fan Jia; Xinyue Cui; Zian Pan; Yan Wu
Journal:  J Nanobiotechnology       Date:  2022-05-12       Impact factor: 9.429

Review 9.  Gene delivery for immunoengineering.

Authors:  Sarah Y Neshat; Stephany Y Tzeng; Jordan J Green
Journal:  Curr Opin Biotechnol       Date:  2020-06-15       Impact factor: 10.279
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.